SCHEMBL3322353

SCHEMBL3322353

CCCCCCCC/C=C\CCCCCCCCOc1ccc2c(c1)CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.67
ALDH1A1 P00352 1/20 0.67
HSD17B1 P14061 3/20 0.63
LMNA P02545 2/20 0.63
MAPT P10636 2/20 0.63
RECQL P46063 1/20 0.63
SMN1; SMN2 Q16637 1/20 0.63
STS P08842 10/20 0.63
CA1 P00915 3/20 0.59
CA2 P00918 3/20 0.59
CA9 Q16790 3/20 0.59
ESR1 P03372 2/20 0.59
ESR2 Q92731 2/20 0.59
ABCC4 O15439 1/20 0.59
CYP2C9 P11712 1/20 0.59
ABCC1 P33527 1/20 0.59
SLCO1B1 Q9Y6L6 1/20 0.59
CA4 P22748 1/20 0.59
CA6 P23280 1/20 0.59
CYP3A4 P08684 3/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6691697 0.92 HSD17B1 (0.74) KDM4EALDH1A1HSD17B1LMNAMAPT
SCHEMBL10134113 0.92 HSD17B1 (0.74) KDM4EALDH1A1HSD17B1LMNAMAPT
SCHEMBL3324357 0.88 KDM4E (0.65) KDM4EALDH1A1HSD17B1LMNAMAPT
SCHEMBL11672003 0.88 HSD17B1 (0.74) KDM4EALDH1A1HSD17B1LMNAMAPT
SCHEMBL14044784 0.88 HSD17B1 (0.74) KDM4EALDH1A1HSD17B1LMNAMAPT
Oleoylestrone SCHEMBL14803698 0.87 KDM4E (0.62) KDM4EALDH1A1HSD17B1LMNAMAPT
Oleoylestrone SCHEMBL2669491 0.87 KDM4E (0.62) KDM4EALDH1A1HSD17B1LMNAMAPT
Oleoylestrone SCHEMBL8069581 0.87 KDM4E (0.62) KDM4EALDH1A1HSD17B1LMNAMAPT
SCHEMBL10037069 0.87 KDM4E (0.62) KDM4EALDH1A1HSD17B1LMNAMAPT
Oleoylestrone SCHEMBL38079 0.87 KDM4E (0.62) KDM4EALDH1A1HSD17B1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100119595-A1 Monounsaturated fatty acids and perhydrocyclopentanophenanthrene nucleus combination molecules, and their precursors, and the use of all of these as weight-loss agents GIROUARD MICHAEL P 2010-05-13 US disclosed
CN-101528730-A Substituted imidazoles as bombesin receptor subtype-3 modulators MERCK & CO INC (US) 2009-09-09 CN disclosed
EP-1594481-A4 MONOUNSATURATED FATTY ACIDS AND PERHYDROCYCLOPENTANOPHENANTHRENE NUCLEUS COMBINATION MOLECULES, AND THEIR PRECURSORS, AND THE USE OF ALL OF THESE AS WEIGHT-LOSS AGENTS GIROUARD MICHAEL P (US) 2006-05-17 EP disclosed
EP-1594481-A2 MONOUNSATURATED FATTY ACIDS AND PERHYDROCYCLOPENTANOPHENANTHRENE NUCLEUS COMBINATION MOLECULES, AND THEIR PRECURSORS, AND THE USE OF ALL OF THESE AS WEIGHT-LOSS AGENTS Girouard, Michael P. (US) 2005-11-16 EP disclosed
US-20040157816-A1 Monounsaturated fatty acids and perhydrocyclopentanophenanthrene nucleus combination molecules, and their precursors, and the use of all of these as weight-loss agents GIROUARD MICHAEL P (US) 2004-08-12 US disclosed
WO-2004045560-A2 COMBINATION OF MONOUNSATURATED FATTY ACIDS AND ESTOGEN, AND THEIR USE GIROUARD MICHAEL P (US) 2004-06-03 WO disclosed